Clinical trials recruiting in Ozark, Missouri

Phase breakdown

Conditions recruiting in Ozark, Missouri

Recruiting trials in Ozark, Missouri

• A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
  NCT07011745 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female)
• A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
  NCT06735248 · Phase: Phase 2 · Ages: 18 Years to 55 Years · Sex: All (male and female)
• Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
  NCT04743141 · Phase: Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female)
• Randomized Study in Children and Adolescents With Migraine: Acute Treatment
  NCT04649242 · Phase: Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female)
• Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
  NCT05125302 · Phase: Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Ozark, Missouri?

5 recruiting trials have at least one study site in Ozark, Missouri.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.